technical analysis

A few day rally could change the picture, but right now it appears that more dollar weakness lies ahead.
There is a bullish divergence from the momentum study, and we can see the On-Balance-Volume line starting to advance.
Technicals are bullish, and the recent rally has been confirmed in the charts.
Momentum readings are improving.
Breakouts to new highs should be accompanied by significantly greater volume, and we're not seeing that yet.
We're watching the SPDR S&P Biotech ETF for clues to a rally. Rejected lows in the charts have been encouraging.
Buyers stepped up in September, and the odds of breaking the recent downtrend are improving.
The fundamentals are just as compelling as the technicals.
The charts show bullish divergences in both stocks. Jack could pop 20%, and DineEquity has 10% upside.
And another look at the gold miners ETF.

Columnist Conversations
I'm in a buy mode at the moment, but think it's a good idea to ratchet up stops on longs in Crude...the video ...
Have a great weekend as well. DXD chart for viewing pleasure. DXD working on ninth straight negative close, ...
As we might expect, the big decline in Oil prices triggered a mirror-image reverse trend in the CAD vs. USD, w...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.